Dehydrated Aloe Vera Impregnated Medicated Gauze

Abstract

The present invention relates to a medicated gauze impregnated with a dehydrated aloe vera extract. The medicated gauze is designed to treat deep wounds, topical burns and dry skin. The medicated gauze is produced by soaking the gauze in an aloe vera extract, drying the gauze in a sterile dehydrator, and then rolling the dried gauze into packages. When the medicated gauze is applied to a wound, the dehydrated aloe vera extract is hydrated by the patient's body moisture to create an aloe vera gel environment conducive to preventing infection and promoting wound healing while avoiding damage to surrounding skin.

Claims

1. A medicated gauze comprising: a dehydrated aloe vera extract; an antimicrobial layer; and an absorption layer.

2. The medicated gauze of claim 1, wherein the antimicrobial layer is impregnated with the dehydrated aloe vera extract.

3. The medicated gauze of claim 1, wherein the absorption layer is impregnated with the dehydrated aloe vera extract.

4. The medicated gauze of claim 1, wherein the dehydrated aloe vera extract is comprised of an aloe vera gel.

5. The medicated gauze of claim 4, wherein the dehydrated aloe vera extract is comprised of 100% aloe vera gel.

6. The medicated gauze of claim 1, wherein the aloe vera extract is derived from an aloe vera barbadensis plant or an aloe vera barbadensis Miller plant.

7. A process for producing a medicated gauze comprising the steps of: soaking a gauze in an aloe vera extract; drying the gauze in a sterile dehydrator; and rolling the gauze to form a package of medicated gauze.

8. The process for producing a medicated gauze of claim 7, wherein the soaking of the gauze in the aloe vera extract occurs for at least one hour.

9. The process for producing a medicated gauze of claim 7, wherein the gauze is comprised of an antimicrobial layer and an absorption layer.

10. The process for producing a medicated gauze of claim 7, wherein the aloe vera extract is comprised of an aloe vera gel.

11. The process for producing a medicated gauze of claim 10, wherein the aloe vera extract is comprised of 100% aloe vera gel.

12. The process for producing a medicated gauze of claim 7, wherein the aloe vera extract is derived from an aloe vera barbadensis plant or an aloe vera barbadensis Miller plant.

13. The process for producing a medicated gauze of claim 7, wherein the gauze is dried in the sterile dehydrator for a duration of time ranging from 24 hours to 48 hours.

14. A process for treating a wound comprising the steps of: providing a medicated gauze; and laying the medicated gauze over the wound or packing the medicated gauze into the wound, wherein a moisture from the wound hydrates the medicated gauze.

15. The process for treating a wound of claim 14, wherein the medicated gauze is comprised of an antimicrobial layer, an absorption layer and a dehydrated aloe vera extract.

16. The process for treating a wound of claim 15, wherein the antimicrobial layer is impregnated with the dehydrated aloe vera extract.

17. The process for treating a wound of claim 15, wherein the absorption layer is impregnated with the dehydrated aloe vera extract.

18. The process for treating a wound of claim 15, wherein the dehydrated aloe vera extract is comprised of an aloe vera gel.

19. The process for treating a wound of claim 15, wherein the dehydrated aloe vera extract is comprised of 100% aloe vera gel.

20. The process for treating a wound of claim 15, wherein the dehydrated aloe vera extract is derived from an aloe vera barbadensis plant or an aloe vera barbadensis Miller plant.

Description

BRIEF DESCRIPTION OF THE DRAWINGS

[0014] The description refers to provided drawings in which similar reference characters refer to similar parts throughout the different views, and in which:

[0015] FIG. 1A illustrates a perspective view of one potential embodiment of the medicated gauze impregnated with dehydrated aloe vera extract in accordance with the disclosed architecture;

[0016] FIG. 1B illustrates the composition of the aloe vera extract of one potential embodiment of the present invention in accordance with the disclosed architecture;

[0017] FIG. 2 illustrates a flow diagram showing steps in producing one potential embodiment of the medicated gauze of the present invention in accordance with the disclosed architecture;

[0018] FIG. 3 illustrates standalone rolls of one potential embodiment of the medicated gauze of the present invention in accordance with the disclosed architecture;

[0019] FIG. 4 illustrates one potential embodiment of the medicated gauze of the present invention incorporated into a bandage in accordance with the disclosed architecture; and

[0020] FIG. 5 illustrates a flow diagram showing exemplary steps performed in treating a wound with one potential embodiment of the medicated gauze of the present invention in accordance with the disclosed architecture.

DETAILED DESCRIPTION OF THE PRESENT INVENTION

[0021] The innovation is now described with reference to the drawings, wherein like reference numerals are used to refer to like elements throughout. In the following description, for purposes of explanation, numerous specific details are set forth to provide a thorough understanding thereof. It may be evident, however, that the innovation can be practiced without these specific details. In other instances, well-known structures and devices are shown in block diagram form to facilitate a description thereof. Various embodiments are discussed hereinafter. It should be noted that the figures are described only to facilitate the description of the embodiments. They are not intended as an exhaustive description of the invention and do not limit the scope of the invention. Additionally, an illustrated embodiment need not have all the aspects or advantages shown. Thus, in other embodiments, any of the features described herein from different embodiments may be combined.

[0022] As noted above, there exists a long-felt need in the art for a hypoallergenic, medicated gauze that relieves pain, prevents infection, promotes wound healing, and does not damage the wound or healthy areas around the wound, or cause other adverse reactions. Furthermore, there is a long-felt need in the art for a method of producing a medicated gauze that will allow for an affordable product in high volume. Finally, there is a long-felt need in the art for a method of using a medicated gauze to treat deep wounds, topical burns, and dry skin.

[0023] Referring initially to the drawings, FIG. 1A illustrates a perspective view of one exemplary embodiment of the invention, a medicated gauze impregnated with a dehydrated aloe vera extract, in accordance with the disclosed architecture. The medicated gauze 100 of the present invention is designed as an affordable and hypoallergenic medicated gauze or bandage that combines a conventional gauze with the unique healing properties of the aloe vera plant as a topical applicant. The medicated gauze 100 works to promote quick and easy healing of dry, damaged skin, and deep wounds. It should be noted that the term “medicated” in the present description is meant that the gauze, bandage, or patch is comprised of the composition hereto described in accordance with the present invention, e.g., a gauze impregnated with a dehydrated aloe vera extract.

[0024] More specifically, the medicated gauze 100 includes an antimicrobial layer 102 made from antimicrobial fibers and an absorption layer 104 made from absorbent fibers. The gauze 100 has a dehydrated aloe vera extract 106 as an active ingredient. The antimicrobial layer and the absorbent layer are impregnated with the dehydrated aloe vera extract 106. The antimicrobial layer 102 contacts the wound and surrounding skin when the gauze 100 is applied to a wound. The body moisture present in the wound hydrates the aloe vera extract to create an aloe vera gel environment only in the area of the wound; thus, preventing surrounding skin from becoming oversaturated and damaged by a topical agent. The gauze 100 is preferably hypoallergenic, paraben-free, sulfate-free, triclosan-free, and vegan.

[0025] Referring to FIG. 1B, the composition of the aloe vera extract 106 of the medicated gauze 100 is illustrated. The aloe vera extract 106 is comprised of aloe vera gel 108. The relative composition of these components is approximately 100% (by weight) aloe vera gel 108.

[0026] In another exemplary embodiment of the present invention, a method for producing a medicated gauze impregnated with a dehydrated aloe vera extract is described. FIG. 2 illustrates a flow diagram showing steps in the production of the medicated gauze 100 of the present invention in accordance with the disclosed architecture. Initially, a gauze is soaked for approximately 1-2 hours in an aloe vera extract, wherein said aloe vera extract is derived from an aloe vera plant such as but not limited to aloe vera barbadensis or aloe vera barbadensis Miller (Step 202). Then, the gauze is placed in a sterile dehydrator providing uniform air circulation for approximately 24 to 48 hours; thereby, causing the gauze to be impregnated with a dehydrated aloe vera extract (Step 204). Thereafter, the gauze is rolled to form a sterile package available in standard rolls of various lengths (Step 206). The medicated gauze 100, produced in this manner can be stored for prolonged periods of time, and can be cut into various lengths and widths for use on differently sized wounds.

[0027] FIG. 3 illustrates standalone rolls of the medicated gauze 100 of the present invention in accordance with the disclosed architecture. The gauze 100 is available in standalone rolls 400 of various sizes such as, but not limited to: 4 cm×50 cm, 3 cm×40 cm and 6 cm×100 cm for example. Further, the gauze 100 may come in paraffin white color or any color that may or may not match the skin tone of a user. The rolls 300 are contained in sterile packaging and can be cut into various lengths and widths for use on differently size wounds.

[0028] FIG. 4 illustrates how the mediated gauze 100 can be incorporated into a bandage. The bandage 400 having an adhesive area 402 which adheres to a patient's skin and a non-adhesive area composed of the medicated gauze 100. The bandages can be made in various sizes and shapes.

[0029] FIG. 5 illustrates a flow diagram showing exemplary steps performed in treating a wound with the dehydrated aloe vera impregnated medicated gauze in accordance with the disclosed architecture. Initially, the gauze 100 is placed loosely over or packed into the wound (Step 502). Then, the dehydrated aloe vera extract is hydrated by the patient's body moisture, naturally present during various wound stages (Step 504). The hydrated aloe vera extract creates an antimicrobial gel environment which quickens the healing process of the wound without over-saturating the wound and surrounding skin (Step 506). The medicated gauze 100 can be used to treat deep wounds as well as for topical burns and dry skin to promote quick and natural healing.

[0030] Certain terms are used throughout the following description and claims to refer to particular features or components. As one skilled in the art will appreciate, different persons may refer to the same feature or component by different names. This document does not intend to distinguish between components or features that differ in name but not structure or function. As used herein “medicated gauze”, “medicated gauze”, “gauze”, “bandage” and “dehydrated aloe vera impregnated medicated gauze” are interchangeable and refer to the dehydrated aloe vera impregnated medicated gauze 100 of the present invention.

[0031] Notwithstanding the forgoing, the dehydrated aloe vera impregnated medicated gauze 100 of the present invention can be of any suitable size and configuration as is known in the art without affecting the overall concept of the invention, provided it accomplishes the above-stated objectives. One of ordinary skill in the art will appreciate that the dehydrated aloe vera impregnated medicated gauze 100 as shown in the FIGS. are for illustrative purposes only, and that many other sizes and shapes of the dehydrated aloe vera impregnated medicated gauze 100 are well within the scope of the present disclosure. Although the dimensions of the dehydrated aloe vera impregnated medicated gauze 100 are important design parameters for user convenience, the dehydrated aloe vera impregnated medicated gauze 100 may be of any size that ensures optimal performance during use and/or that suits the user's needs and/or preferences.

[0032] Various modifications and additions can be made to the exemplary embodiments discussed without departing from the scope of the present invention. While the embodiments described above refer to particular features, the scope of this invention also includes embodiments having different combinations of features and embodiments that do not include all the described features. Accordingly, the scope of the present invention is intended to embrace all such alternatives, modifications, and variations as fall within the scope of the claims, together with all equivalents thereof.

[0033] What has been described above includes examples of the claimed subject matter. It is, of course, not possible to describe every conceivable combination of components or methodologies for purposes of describing the claimed subject matter, but one of ordinary skill in the art may recognize that many further combinations and permutations of the claimed subject matter are possible. Accordingly, the claimed subject matter is intended to embrace all such alterations, modifications and variations that fall within the spirit and scope of the appended claims. Furthermore, to the extent that the term “includes” is used in either the detailed description or the claims, such term is intended to be inclusive in a manner similar to the term “comprising” as “comprising” is interpreted when employed as a transitional word in a claim.